This announcement is a separate document:
华泰联合证券有限责任公司关于江苏浩欧博生物医药股份有限公司2024年半年度持续督导跟踪报告
Huatai United Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Jiangsu Haobo Biomedical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.